Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/02/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 11/30/25
Due: 11/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)® | NCT05900050 | Versantis AG | user2@example.com | None | 2023-07-02 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy | NCT06987968 | Versantis AG | user2@example.com | None | 2025-06-30 | 2025-11-30 | 2026-11-30 | - | - | 2025-07-14 |